Though not every anti-diabetic medicine is beneficial for weight reduction in non-diabetics, GLP-1-RAs, particularly semaglutide, stand out for their pleiotropic effects in this regard [7, 9, 14, 15]
Medical weight loss typically involves the use of various interventions, including medications, to assist individuals in achieving their weight loss goals under the guidance of healthcare professionals
Lets compare them closely
A 2023 case series published in the Journal of Clinical Psychopharmacology reported on six patients with BED treated with semaglutide, five of whom experienced substantial reductions in binge frequency and loss of control eating
The FDA label recommends using a non-oral contraceptive method or adding a barrier method for 4 weeks after starting tirzepatide and after each dose increase